Member Info for Lostapound

Stuff your advice. I'm not selling.

Like I said, I was explaining why Hemogenyx mentioned the funding issue in THEIR OWN prospectus. I've repeated lots of times I didn't expect an instant need for cash. But don't let that get in the way of your own delusions. I feel sorry you.

Now let me say again, my average is £1.80. Now let me sit here with my smug face on whilst the Hemo cultees wait for £30 to break even.

This 'car' is not stationary.

Another slap on the wrist from the cult. Don't explain why Vlad mentioned the cash shortfall. I would think everyone now understands your relationship with facts - you detest them

The head of cult speaks....

Low and behold, it's wrong again.

The price rises and my profits grow 🤑.

Tell us that one about how last year Hemo were spending £250k per month 😂.

Hey Micky I never said they needed money, I just pointed that Hemogenyx said they needed money for 2026.

But some of you are part of the cult arm of Hemo investors, and that fries the brains.

CASH POSITION AFTER ALL DISCLOSED RAISES

Starting point (reported):

£226,727 cash at 30 June 2025

Post‑period inflows disclosed:

- £2,215,799 raised after 30 June

- £190,000 from warrant exercises (Dec 2025)

Total gross cash available entering H2 2025:

≈ £2.63 million

Burn rate (from H1 2025)

The half‑year cash flow statement shows:

- Net operating cash outflow: £3,783,209

- That’s ~£630k per month

- This includes a large FX loss, but even stripping that out, the underlying burn is still £450k–£550k per month

To stay conservative, use £550k/month as the operational burn.

Known planned spend: Made Scientific transfer (£1m)

The prospectus indicates £1 million is earmarked for the Made Scientific tech transfer.

This is not optional; it’s part of the clinical and manufacturing plan.

ESTIMATED RUNWAY

Start with £2.63m

Subtract £1m for Made Scientific

Leaves ≈ £1.63m

Divide by burn £550k/month:

Runway ≈ 3 months

If you use the full H1 burn rate (£630k/month):

Runway ≈ 2.5 months

This aligns with the prospectus warning that they will run out of working capital in Q1 2026.

SUMMARY

After all disclosed raises, Hemogenyx enters late 2025 with ~£2.6m gross, but only ~£1.6m usable after the Made Scientific commitment.

- At their burn rate, this gives 2.5–3 months of runway.

- This is why the prospectus explicitly states they need new funding in Q1 2026 to continue operations and complete Phase I.

As usual, this is working on the provided known public information, not guessed and made up figures.

Have a good weekend MrIndia. I hope you have some nice plans with all that money from this week's sells.

MrIndia when you stop calling me a shorter or trader, or making up lies about me, I will stop telling everyone about your sells. Simple really.

Unfortunately you have people like MrIndia, selling blocks of 500 and 1000 to keep the price from rising to £12. Our rocket will blast off to the moon soon. MrIndia's should be a 1 way ticket to the sun.

I'm anticipating Made transfer completion to be around early March time, assuming all goes to plan.

Some sort of news will be needed to maintain and keep the momentum.

11s

After being rounded on for a non ramping post, that's what you get.

I only know Fibonacci as in the sequence.

Thank you @HereforHemo . I agree, any form of presentation at this type of event is good. But I would also guess that if there were any serious takeover discussions or JV, the BP would be wanting silence from Hemo, hence my question.

If you don't know the answer, or don't like the answer, just say. Leave it to someone else to answer.

I'm sorry if you don't like it; it's a serious question. Every one of these conferences: "Look at these deals that have been done in previous years; we'll definitely get a deal," a LoI.

Next one: "We'll definitely get a deal; this one is even bigger. Look at all these deals that have been done in previous years." Silence.

Next one: "Look at all these deals that have been done in previous years..."

Does that mean no imminent funding from the other conference?

Trade errors?

In around 2 to 3 weeks, it will be the 12-month period since P1's treatment. Will we get an update around this time regarding all three patients?

Made transfer news: I'm expecting it in early March, based on Made's own transfer timelines, etc.